| 0.9347 0.015 (1.64%) | 07-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.15 | 1-year : | 1.24 |
| Resists | First : | 0.98 | Second : | 1.07 |
| Pivot price | 0.93  |
|||
| Supports | First : | 0.85 | Second : | 0.7 |
| MAs | MA(5) : | 0.92 |
MA(20) : | 0.95 |
| MA(100) : | 1.2 |
MA(250) : | 1.46 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 35.4 |
D(3) : | 35.1 |
| RSI | RSI(14): 43.3 |
|||
| 52-week | High : | 2.24 | Low : | 0.85 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ OGI ] has closed below upper band by 47.5%. Bollinger Bands are 35.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.94 - 0.95 | 0.95 - 0.95 |
| Low: | 0.9 - 0.9 | 0.9 - 0.91 |
| Close: | 0.93 - 0.93 | 0.93 - 0.94 |
Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.
Fri, 24 Jul 2026
Sanity Group Acquisition Boosts Organigram's Quarterly Revenue - Seeking Alpha
Fri, 24 Jul 2026
Organigram Global Inc. Revenue Breakdown – NASDAQ:OGI - TradingView
Tue, 21 Jul 2026
Organigram Highlights Strong Canadian Cannabis Position and Solid Early Performance from Sanity Acquisition - The Globe and Mail
Mon, 20 Jul 2026
Organigram Global (NASDAQ: OGI) details Sanity gains and Canadian share - Stock Titan
Mon, 20 Jul 2026
Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share - Business Wire
Sun, 31 May 2026
Organigram Global Inc (OGI) Raises 2026 Guidance on Sanity Acquisition - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 141 (M) |
| Shares Float | 98 (M) |
| Held by Insiders | 30.2 (%) |
| Held by Institutions | 6.5 (%) |
| Shares Short | 5,840 (K) |
| Shares Short P.Month | 5,420 (K) |
| EPS | -0.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.91 |
| Profit Margin | -9.2 % |
| Operating Margin | -16.4 % |
| Return on Assets (ttm) | -1.7 % |
| Return on Equity (ttm) | -6 % |
| Qtrly Rev. Growth | -8.9 % |
| Gross Profit (p.s.) | 0.69 |
| Sales Per Share | 1.94 |
| EBITDA (p.s.) | 0.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -10 (M) |
| Levered Free Cash Flow | 16 (M) |
| PE Ratio | -6.24 |
| PEG Ratio | 0 |
| Price to Book value | 0.48 |
| Price to Sales | 0.47 |
| Price to Cash Flow | -13.71 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|